"Anabolic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
These compounds stimulate anabolism and inhibit catabolism. They stimulate the development of muscle mass, strength, and power.
| Descriptor ID |
D045930
|
| MeSH Number(s) |
D27.505.696.399.472.080
|
| Concept/Terms |
Anabolic Effect- Anabolic Effect
- Effect, Anabolic
- Anabolic Effects
- Effects, Anabolic
|
Below are MeSH descriptors whose meaning is more general than "Anabolic Agents".
Below are MeSH descriptors whose meaning is more specific than "Anabolic Agents".
This graph shows the total number of publications written about "Anabolic Agents" by people in this website by year, and whether "Anabolic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anabolic Agents" by people in Profiles.
-
Jasuja R, Costello JC, Singh R, Gupta V, Spina CS, Toraldo G, Jang H, Li H, Serra C, Guo W, Chauhan P, Narula NS, Guarneri T, Ergun A, Travison TG, Collins JJ, Bhasin S. Combined administration of testosterone plus an ornithine decarboxylase inhibitor as a selective prostate-sparing anabolic therapy. Aging Cell. 2014 Apr; 13(2):303-10.
-
Yuan Q, Sato T, Densmore M, Saito H, Sch?ler C, Erben RG, Lanske B. FGF-23/Klotho signaling is not essential for the phosphaturic and anabolic functions of PTH. J Bone Miner Res. 2011 Sep; 26(9):2026-35.
-
Santamarina RD, Besocke AG, Romano LM, Ioli PL, Gonorazky SE. Ischemic stroke related to anabolic abuse. Clin Neuropharmacol. 2008 Mar-Apr; 31(2):80-5.
-
Akyurek M, Dunn RM. Oxandrolone. Plast Reconstr Surg. 2006 Sep; 118(3):791-4.
-
Schneider GB, Grecco KJ, Safadi FF, Popoff SN. The anabolic effects of vitamin D-binding protein-macrophage activating factor (DBP-MAF) and a novel small peptide on bone. Crit Rev Eukaryot Gene Expr. 2003; 13(2-4):277-84.
-
Dickerman RD, Pertusi RM, Zachariah NY, Dufour DR, McConathy WJ. Anabolic steroid-induced hepatotoxicity: is it overstated? Clin J Sport Med. 1999 Jan; 9(1):34-9.
-
Nicolaescu T, Bittman E, Stoiculescu P. [Current treatment of aggressive chronic hepatitis]. Med Interna (Bucur). 1971 Dec; 23(12):1471-9.
-
Nicolaescu T, Bordeianu A, Bittman E, Gabrielescu E, Stoiculescu P, Dragulescu N. [Factors stimulating liver regeneration; role of anabolic steroids in reactive regeneration in chronic liver diseases]. Rev Roum Physiol. 1969; 6(2):119-26.
-
Nicolaescu T, Bordeianu A, Bittman E, Dragulescu N. [Lipodystrophy of the liver and steroid treatment of chronic liver diseases]. Rev Int Hepatol. 1967; 17(4):367-76.